Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


20.11.2017

3 Ann Rheum Dis
4 Arthritis Res Ther
2 Clin Exp Immunol
5 Clin Exp Rheumatol
3 Clin Rheumatol
1 Drugs
1 J Intern Med
5 J Rheumatol
3 PLoS One
1 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. MO WX, Yin SS, Chen H, Zhang X, et al
    Amino-bisphosphonates, gammadeltaT cells, and their roles in Rheumatoid Arthritis.
    Ann Rheum Dis. 2017 Nov 17. pii: annrheumdis-2017-212569.
    PubMed     Text format    

  2. KAVANAUGH A, van Vollenhoven R, Fleischmann RM, Emery P, et al
    Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis.
    Ann Rheum Dis. 2017 Nov 16. pii: annrheumdis-2017-211871.
    PubMed     Text format     Abstract available

  3. L'AMI MJ, Krieckaert CLM, Nurmohamed MT, van Vollenhoven RF, et al
    Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.
    Ann Rheum Dis. 2017 Nov 13. pii: annrheumdis-2017-212602.
    PubMed     Text format    


    Arthritis Res Ther

  4. BLACK RJ, Lester S, Buchbinder R, Barrett C, et al
    Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry.
    Arthritis Res Ther. 2017;19:253.
    PubMed     Text format     Abstract available

  5. ZHOU L, Wang G, Liu X, Song J, et al
    Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:250.
    PubMed     Text format     Abstract available

  6. ANAPARTI V, Smolik I, Meng X, Spicer V, et al
    Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects.
    Arthritis Res Ther. 2017;19:249.
    PubMed     Text format     Abstract available

  7. JIN S, Li M, Fang Y, Li Q, et al
    Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:251.
    PubMed     Text format     Abstract available


    Clin Exp Immunol

  8. XU L, Hu F, Zhu H, Liu X, et al
    Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: Correlation with disease activity and bone destruction.
    Clin Exp Immunol. 2017 Nov 17. doi: 10.1111/cei.13082.
    PubMed     Text format     Abstract available

  9. LI J, Xu B, Wu C, Yan X, et al
    TXNDC5 Contributes to Rheumatoid Arthritis by Down-regulating IGFBP1 Expression.
    Clin Exp Immunol. 2017 Nov 13. doi: 10.1111/cei.13080.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  10. MA MHY, Ibrahim F, Kingsley GH, Cope A, et al
    Variable impacts of different remission states on health-related quality of life in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  11. TWEEHUYSEN L, Schraa K, Netea MG, van den Hoogen FHJ, et al
    Ex-vivo inhibited cytokine profiling explains inferior treatment response to golimumab after adalimumab failure in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  12. POPE JE, Rampakakis E, Movahedi M, Cesta A, et al
    Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: data from the Ontario Best Practices Research Initiative (OBRI).
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  13. NAGAI T, Matsueda Y, Tomita T, Yoshikawa H, et al
    The expression of mRNA for peptidylarginine deiminase type 2 and type 4 in bone marrow CD34+ cells in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  14. THOMAS K, Flouri I, Repa A, Fragiadaki K, et al
    High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  15. HASSINE HB, Sghiri R, Chabchoub E, Boumiza A, et al
    IRAK2 is associated with susceptibility to rheumatoid arthritis.
    Clin Rheumatol. 2017 Nov 11. doi: 10.1007/s10067-017-3906.
    PubMed     Text format     Abstract available

  16. WANG L, Tan W, Wang F, Shen Y, et al
    Artery compliance in patients with rheumatoid arthritis: results from a case-control study.
    Clin Rheumatol. 2017 Nov 13. doi: 10.1007/s10067-017-3899.
    PubMed     Text format     Abstract available

  17. CHARLES-SCHOEMAN C, Meriwether D, Lee YY, Shahbazian A, et al
    High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.
    Clin Rheumatol. 2017 Nov 11. doi: 10.1007/s10067-017-3896.
    PubMed     Text format     Abstract available


    Drugs

  18. DHILLON S
    Tofacitinib: A Review in Rheumatoid Arthritis.
    Drugs. 2017 Nov 14. doi: 10.1007/s40265-017-0835.
    PubMed     Text format     Abstract available


    J Intern Med

  19. SARAJLIC P, Friden C, Lund LH, Manouras A, et al
    Enhanced ventricular-arterial coupling during a 2-year physical activity program in patients with rheumatoid arthritis.
    J Intern Med. 2017 Nov 15. doi: 10.1111/joim.12715.
    PubMed     Text format     Abstract available


    J Rheumatol

  20. SODE J, Krintel SB, Carlsen AL, Hetland ML, et al
    Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170266. doi: 10.3899/jrheum.170266.
    PubMed     Text format     Abstract available

  21. LAU AN, Wong-Pack M, Rodjanapiches R, Ioannidis G, et al
    Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting.
    J Rheumatol. 2017 Nov 15. pii: jrheum.161270. doi: 10.3899/jrheum.161270.
    PubMed     Text format     Abstract available

  22. RICHTER JG, Muth T, Li J, Brinks R, et al
    Elevated Psychosocial Stress at Work in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170233. doi: 10.3899/jrheum.170233.
    PubMed     Text format     Abstract available

  23. CHARLES-SCHOEMAN C, van der Heijde D, Burmester GR, Nash P, et al
    Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170486. doi: 10.3899/jrheum.170486.
    PubMed     Text format     Abstract available

  24. CURTIS JR, Chen L, Danila MI, Saag KG, et al
    Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid Arthritis.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170548. doi: 10.3899/jrheum.170548.
    PubMed     Text format     Abstract available


    PLoS One

  25. STACK JR, Madigan A, Helbert L, Dunne E, et al
    Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.
    PLoS One. 2017;12:e0188027.
    PubMed     Text format     Abstract available

  26. YUAN M, Wang S, Yu L, Qu B, et al
    Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0186795.
    PubMed     Text format     Abstract available

  27. STACK RJ, Southworth S, Fisher BA, Barone F, et al
    A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjogren's Syndrome.
    PLoS One. 2017;12:e0187272.
    PubMed     Text format     Abstract available


    Rheumatol Int

  28. BAGANZ L, Richter A, Kekow J, Bussmann A, et al
    Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
    Rheumatol Int. 2017 Nov 16. doi: 10.1007/s00296-017-3870.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: